|
|
||||||||
2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo
1Departments of Pathophysiology and Nephrology, University of Essen Medical School, D-45147 Essen; and 2Institute of Pharmacology and 3Department of Anesthesiology, Martin-Luther-University of Halle, D-06097 Halle, Germany
Submitted 10 April 2003 ; accepted in final form 8 July 2003
In subjects heterozygous for Thr164Ile
2-adrenoceptor (
2AR) polymorphism, cardiac responses to
2AR agonist stimulation are blunted. In this study, we investigated agonist-induced desensitization of Thr164Ile
2ARs. For this purpose, we assessed in six subjects with heterozygous Thr164Ile
2ARs and in 10 subjects with homozygous wild-type (WT)
2ARs the effects of 2-wk oral treatment with 3 x 5 mg/day terbutaline on terbutaline infusion-induced increases in heart rate (HR) and contractility [measured as shortening of HR-corrected duration of electromechanical systole (QS2c)]. Compared with WT
2AR subjects, Thr164Ile subjects exhibited a blunted terbutaline-induced maximum increase in HR (WT 32 ± 4 beats/min, Thr164Ile 19 ± 3 beats/min, P < 0.05) and contractility (WT 54 ± 2 ms, Thr164Ile 37 ± 6 ms, P < 0.05). Two-week oral terbutaline treatment desensitized cardiac
2AR responses to terbutaline infusion (increase in HR: WT 10 ± 2 beats/min, Thr164Ile 8 ± 4 beats/min; increase in contractility: WT 22 ± 5 ms Thr164Ile: 17 ± 6 ms); however, the extent of desensitization was larger in WT than Thr164Ile
2AR subjects. Thus, after 2-wk oral terbutaline treatment cardiac,
2AR responses did not differ anymore between WT and Thr164Ile
2AR subjects. We conclude that agonist-induced desensitization of cardiac
2ARs is more pronounced in WT than Thr164Ile subjects. Thus cardiac Thr164Ile subjects appear to be somewhat protected against agonist-induced desensitization.
genetic polymorphism; heart rate; contractility
This article has been cited by other articles:
![]() |
D. Rosskopf and M. C. Michel Pharmacogenomics of G Protein-Coupled Receptor Ligands in Cardiovascular Medicine Pharmacol. Rev., December 1, 2008; 60(4): 513 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barbato, M. Penicka, L. Delrue, F. Van Durme, B. De Bruyne, M. Goethals, W. Wijns, M. Vanderheyden, and J. Bartunek Thr164Ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |